Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Drug Combinations"" wg kryterium: Temat


Tytuł :
Drug combination therapy for emerging viral diseases.
Autorzy :
Shyr ZA; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA. Electronic address: .
Cheng YS; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
Lo DC; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.
Zheng W; National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA. Electronic address: .
Pokaż więcej
Źródło :
Drug discovery today [Drug Discov Today] 2021 Oct; Vol. 26 (10), pp. 2367-2376. Date of Electronic Publication: 2021 May 21.
Typ publikacji :
Journal Article; Research Support, N.I.H., Intramural; Review
MeSH Terms :
Drug Combinations*
Antiviral Agents/*therapeutic use
Communicable Diseases, Emerging/*drug therapy
Drug Therapy, Combination/*trends
Virus Diseases/*drug therapy
COVID-19/drug therapy ; Drug Repositioning ; Humans
Czasopismo naukowe
Tytuł :
The future of antibiotics begins with discovering new combinations.
Autorzy :
Zhu M; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.
Tse MW; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.
Weller J; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.
Chen J; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.; Microbiology Graduate Program, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Blainey PC; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Cambridge, Massachusetts.
Pokaż więcej
Źródło :
Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2021 Jul; Vol. 1496 (1), pp. 82-96. Date of Electronic Publication: 2021 Jul 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Drug Combinations*
Anti-Bacterial Agents/*pharmacology
Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/therapeutic use ; Bacterial Infections/drug therapy ; Drug Resistance, Bacterial/drug effects ; Microbial Sensitivity Tests
Czasopismo naukowe
Tytuł :
[Defined daily doses in drugs with combinations of active principles: differences between three calculation methods.]
Autorzy :
Llop Margalef C; Unitat de Farmàcia. Región Sanitaria Camp de Tarragona. CatSalut. Tarragona. España.
Llop Paredes D; Servei d'Epidemiologia i Prevenció del Càncer. Hospital Universitari Sant Joan de Reus. Reus. España.
Guinovart Moncunill M; Unitat de Farmàcia. Región Sanitaria Camp de Tarragona. CatSalut. Tarragona. España.
Pokaż więcej
Transliterated Title :
Dosis diarias definidas en fármacos con combinaciones de principios activos: diferencias entre tres métodos de cálculo.
Źródło :
Revista espanola de salud publica [Rev Esp Salud Publica] 2021 Aug 12; Vol. 95. Date of Electronic Publication: 2021 Aug 12.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Combinations*
Drug Dosage Calculations*
Pharmaceutical Preparations*/administration & dosage
Humans ; Hypoglycemic Agents/administration & dosage ; Spain ; World Health Organization
Czasopismo naukowe
Tytuł :
Comparison of COPD health care utilization and associated costs across patients treated with LAMA+LABA fixed-dose therapies.
Autorzy :
Palli SR; Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT.
Xie B; Optum, Eden Prairie, MN.
Chastek B; Optum, Eden Prairie, MN.
Elliott CA; Optum, Eden Prairie, MN.
Bengtson LGS; Optum, Eden Prairie, MN.
Pokaż więcej
Źródło :
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2021 Jul; Vol. 27 (7), pp. 810-824. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji :
Comparative Study; Journal Article; Observational Study
MeSH Terms :
Drug Combinations*
Patient Acceptance of Health Care*
Adrenergic beta-2 Receptor Agonists/*administration & dosage
Adrenergic beta-2 Receptor Agonists/*economics
Muscarinic Antagonists/*administration & dosage
Muscarinic Antagonists/*economics
Pulmonary Disease, Chronic Obstructive/*drug therapy
Pulmonary Disease, Chronic Obstructive/*economics
Administration, Inhalation ; Aged ; Benzoxazines/administration & dosage ; Benzyl Alcohols/administration & dosage ; Bronchodilator Agents ; Chlorobenzenes/administration & dosage ; Delayed-Action Preparations ; Female ; Humans ; Male ; Middle Aged ; Quinuclidines/administration & dosage ; Retrospective Studies ; Tiotropium Bromide/administration & dosage ; United States
Czasopismo naukowe
Tytuł :
Cocrystal of Apixaban-Quercetin: Improving Solubility and Bioavailability of Drug Combination of Two Poorly Soluble Drugs.
Autorzy :
Zhang L; Beijing City Key Laboratory of Polymorphic Drugs, Center of Pharmaceutical Polymorphs, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Kong D; Beijing City Key Laboratory of Drug Target and Screening Research, National Center for Pharmaceutical Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Wang H; Beijing City Key Laboratory of Polymorphic Drugs, Center of Pharmaceutical Polymorphs, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Jiao L; Beijing City Key Laboratory of Polymorphic Drugs, Center of Pharmaceutical Polymorphs, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Zhao X; Beijing City Key Laboratory of Drug Target and Screening Research, National Center for Pharmaceutical Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Song J; Beijing City Key Laboratory of Drug Target and Screening Research, National Center for Pharmaceutical Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Yang D; Beijing City Key Laboratory of Polymorphic Drugs, Center of Pharmaceutical Polymorphs, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Yang H; Beijing City Key Laboratory of Drug Target and Screening Research, National Center for Pharmaceutical Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Yang S; Beijing City Key Laboratory of Polymorphic Drugs, Center of Pharmaceutical Polymorphs, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Du G; Beijing City Key Laboratory of Drug Target and Screening Research, National Center for Pharmaceutical Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Lu Y; Beijing City Key Laboratory of Polymorphic Drugs, Center of Pharmaceutical Polymorphs, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2021 May 03; Vol. 26 (9). Date of Electronic Publication: 2021 May 03.
Typ publikacji :
Journal Article
MeSH Terms :
Crystallization*
Drug Combinations*
Solvents*
Pyrazoles/*pharmacology
Pyridones/*pharmacology
Quercetin/*pharmacology
Animals ; Biological Availability ; Calorimetry, Differential Scanning ; Chromatography, High Pressure Liquid ; Fibrinolytic Agents/pharmacology ; Hydrogen Bonding ; Male ; Pharmaceutical Preparations ; Powders ; Pyrazoles/chemistry ; Pyridones/chemistry ; Quercetin/chemistry ; Rats ; Rats, Sprague-Dawley ; Solubility ; Temperature ; Thermogravimetry ; X-Ray Diffraction
Czasopismo naukowe
Tytuł :
Comparison of the effects of butorphanol-midazolam-medetomidine and butorphanol-azaperone-medetomidine in wild common palm civets (Paradoxurus musangus).
Autorzy :
Ahmad AA; Conservation, Research and Veterinary Services, Wildlife Reserves Singapore, Singapore. Electronic address: .
Douay G; Conservation, Research and Veterinary Services, Wildlife Reserves Singapore, Singapore.
Low MR; Conservation, Research and Veterinary Services, Wildlife Reserves Singapore, Singapore.
Fabbri S; The Animal Clinic, Clementi, Singapore.
Chen HC; Universiti Putra Malaysia, Malaysia.
Pokaż więcej
Źródło :
Veterinary anaesthesia and analgesia [Vet Anaesth Analg] 2021 May; Vol. 48 (3), pp. 380-387. Date of Electronic Publication: 2021 Mar 05.
Typ publikacji :
Journal Article; Randomized Controlled Trial, Veterinary
MeSH Terms :
Azaperone*/pharmacology
Drug Combinations*
Medetomidine*/pharmacology
Viverridae*
Animals ; Butorphanol/pharmacology ; Female ; Heart Rate/drug effects ; Hypnotics and Sedatives/pharmacology ; Immobilization/veterinary ; Male ; Midazolam/pharmacology ; Prospective Studies
Czasopismo naukowe
Tytuł :
Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect.
Autorzy :
López-Campos JL; Hospital Universitario Virgen del Rocío-Universidad de Sevilla Seville, Spain.; Instituto de Salud Carlos III-Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES) Madrid, Spain.
Fernández-Villar A; Hospital Álvaro Cunqueiro Vigo, Pontevedra, Spain.
Ruano-Ravina A; Universidad de Santiago de Compostela Santiago, Spain and.; Instituto de Salud Carlos III-Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP) Madrid, Spain.
Pokaż więcej
Źródło :
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2021 Apr 01; Vol. 203 (7), pp. 925-926.
Typ publikacji :
Comparative Study; Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Combinations*
Bronchodilator Agents/*therapeutic use
Budesonide/*therapeutic use
Formoterol Fumarate/*therapeutic use
Glycopyrrolate/*therapeutic use
Pulmonary Disease, Chronic Obstructive/*drug therapy
Pulmonary Disease, Chronic Obstructive/*mortality
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome
Raport
Tytuł :
Contemporary Pharmacotherapeutic Approach in Pulmonary Arterial Hypertension.
Autorzy :
Ahari J; George Washington University School of Medicine and Health Sciences, 2150 Pennsylvania Avenue 4th Floor, Washington, DC 20037, USA.
Bhatnagar A; George Washington University School of Medicine and Health Sciences, 2150 Pennsylvania Avenue 4th Floor, Washington, DC 20037, USA.
Johnson A; George Washington University School of Medicine and Health Sciences, 2150 Pennsylvania Avenue 4th Floor, Washington, DC 20037, USA.
Gomberg-Maitland M; George Washington University School of Medicine and Health Sciences, 2150 Pennsylvania Avenue 4th Floor, Washington, DC 20037, USA. Electronic address: .
Pokaż więcej
Źródło :
Clinics in chest medicine [Clin Chest Med] 2021 Mar; Vol. 42 (1), pp. 125-131. Date of Electronic Publication: 2021 Jan 08.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Combinations*
Drug Therapy, Combination/*methods
Pulmonary Arterial Hypertension/*drug therapy
Humans
Czasopismo naukowe
Tytuł :
Could a Low-Dose Diuretic Polypill Improve Outcomes in Heart Failure With Preserved Ejection Fraction?
Autorzy :
Khan SS; Division of Cardiology, Department of Medicine (S.S.K.,M.D.H., S.J.S.), Northwestern University Feinberg School of Medicine, Chicago, IL.; Department of Preventive Medicine (S.S.K., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL.
Huffman MD; Division of Cardiology, Department of Medicine (S.S.K.,M.D.H., S.J.S.), Northwestern University Feinberg School of Medicine, Chicago, IL.; Department of Preventive Medicine (S.S.K., M.D.H.), Northwestern University Feinberg School of Medicine, Chicago, IL.; The George Institute for Global Health, University of New South Wales, Sydney, Australia (M.D.H.).
Shah SJ; Division of Cardiology, Department of Medicine (S.S.K.,M.D.H., S.J.S.), Northwestern University Feinberg School of Medicine, Chicago, IL.
Pokaż więcej
Źródło :
Circulation. Heart failure [Circ Heart Fail] 2021 Mar; Vol. 14 (3), pp. e008090. Date of Electronic Publication: 2021 Mar 05.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Combinations*
Heart Failure/*drug therapy
Mineralocorticoid Receptor Antagonists/*administration & dosage
Sodium Chloride Symporter Inhibitors/*administration & dosage
Sodium Potassium Chloride Symporter Inhibitors/*administration & dosage
Sodium-Glucose Transporter 2 Inhibitors/*administration & dosage
Heart Failure/physiopathology ; Hospitalization ; Humans ; Stroke Volume
Czasopismo naukowe
Tytuł :
TranSynergy: Mechanism-driven interpretable deep neural network for the synergistic prediction and pathway deconvolution of drug combinations.
Autorzy :
Liu Q; Department of Computer Science, Hunter College, The City University of New York, New York, United States of America.
Xie L; Department of Computer Science, Hunter College, The City University of New York, New York, United States of America.; Ph.D. Program in Computer Science, The City University of New York, New York, United States of America.; Ph.D. Program in Biochemistry and Biology, The City University of New York, New York, United States of America.; Helen and Robert Appel Alzheimer's Disease Research Institute, Feil Family Brain & Mind Research Institute, Weill Cornell Medicine, Cornell University, New York, United States of America.
Pokaż więcej
Źródło :
PLoS computational biology [PLoS Comput Biol] 2021 Feb 12; Vol. 17 (2), pp. e1008653. Date of Electronic Publication: 2021 Feb 12 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Deep Learning*
Drug Combinations*
Neural Networks, Computer*
Computational Biology/*methods
Drug Discovery/*methods
Algorithms ; Antineoplastic Agents ; Computer Simulation ; Drug Evaluation, Preclinical ; Drug Synergism ; Humans ; Precision Medicine
Czasopismo naukowe
Tytuł :
Emerging Multi-Drug Eutectics: Opportunities and Challenges.
Autorzy :
Haneef J; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110 062, India. .
Ali S; Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110 062, India.
Chadha R; University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Studies (CAS), Panjab University, Chandigarh, 160 014, India.
Pokaż więcej
Źródło :
AAPS PharmSciTech [AAPS PharmSciTech] 2021 Feb 07; Vol. 22 (2), pp. 66. Date of Electronic Publication: 2021 Feb 07.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Combinations*
Drug Liberation ; Drug Synergism ; Humans ; Solubility
Czasopismo naukowe
Tytuł :
Anticancer drug synergy prediction in understudied tissues using transfer learning.
Autorzy :
Kim Y; Center for Safe Artificial Intelligence for Healthcare, School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Zheng S; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Tang J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Jim Zheng W; Center for Safe Artificial Intelligence for Healthcare, School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Li Z; Center for Safe Artificial Intelligence for Healthcare, School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Jiang X; Center for Safe Artificial Intelligence for Healthcare, School of Biomedical Informatics, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Pokaż więcej
Źródło :
Journal of the American Medical Informatics Association : JAMIA [J Am Med Inform Assoc] 2021 Jan 15; Vol. 28 (1), pp. 42-51.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Combinations*
Drug Synergism*
Machine Learning*
Neural Networks, Computer*
Antineoplastic Agents/*pharmacology
Drug Screening Assays, Antitumor/*methods
Cell Line, Tumor ; Computational Biology ; Humans ; Models, Theoretical
Czasopismo naukowe
Tytuł :
Efficacy and Safety of Bevacizumab-Combined Chemotherapy for Advanced and Recurrent Endometrial Cancer: A Systematic Review and Meta-analysis.
Autorzy :
Chen H; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liang M; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Min J; Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło :
Balkan medical journal [Balkan Med J] 2021 Jan; Vol. 38 (1), pp. 7-12.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Drug Combinations*
Bevacizumab/*pharmacology
Drug Therapy/*standards
Endometrial Neoplasms/*drug therapy
Drug Therapy/methods ; Female ; Humans ; Randomized Controlled Trials as Topic/statistics & numerical data
Czasopismo naukowe
Tytuł :
Evaluation of assay and in-vitro dissolution profile of certain fixed-dose combination using green analytical method.
Autorzy :
Lotfy HM; Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, Egypt; Pharmaceutical Chemistry Department, Faculty of Pharmaceutical Science and Pharmaceutical Industries, Future University in Egypt, Cairo, Egypt.
Obaydo RH; Department of Analytical and food Chemistry, Faculty of Pharmacy/University of Aleppo, Syria. Electronic address: .
Sakur AA; Department of Analytical and food Chemistry, Faculty of Pharmacy/University of Aleppo, Syria.
Pokaż więcej
Źródło :
Annales pharmaceutiques francaises [Ann Pharm Fr] 2021 Jan; Vol. 79 (1), pp. 3-15. Date of Electronic Publication: 2020 Aug 07.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Combinations*
Green Chemistry Technology/*methods
Anti-Bacterial Agents/chemistry ; Chemistry, Pharmaceutical ; Chromatography, High Pressure Liquid ; Ciprofloxacin/chemistry ; Drug Compounding ; Drug Industry ; Metronidazole/chemistry ; Quality Control ; Reproducibility of Results ; Sensitivity and Specificity ; Solubility ; Solvents ; Spectrophotometry, Ultraviolet ; Tablets
Czasopismo naukowe
Tytuł :
Toxicological analysis of George's marvellous medicine: literature review.
Autorzy :
Johnson G; Emergency Department, University Hospitals of Derby and Burton NHS Foundation Trust, Royal Derby Hospital, Derby DE22 3NE, UK .; University of Nottingham School of Medicine, Nottingham, UK.
Davies P; University of Nottingham School of Medicine, Nottingham, UK.; Paediatric Critical Care Department, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Pokaż więcej
Źródło :
BMJ (Clinical research ed.) [BMJ] 2020 Dec 10; Vol. 371, pp. m4467. Date of Electronic Publication: 2020 Dec 10.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Drug Combinations*
Drug-Related Side Effects and Adverse Reactions*
Medicine in Literature*
Child ; England ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł :
Improving Care for Heart Failure With Reduced Ejection Fraction-A Potential Polypill-Based Strategy.
Autorzy :
Agarwal A; Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Yancy CW; Division of Cardiology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Huffman MD; Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.; George Institute for Global Health, University of New South Wales, Sydney, Australia.
Pokaż więcej
Źródło :
JAMA [JAMA] 2020 Dec 08; Vol. 324 (22), pp. 2259-2260.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Combinations*
Heart Failure/*drug therapy
Adrenergic beta-Antagonists/administration & dosage ; Angiotensin Receptor Antagonists/administration & dosage ; Heart Failure/physiopathology ; Humans ; Medication Adherence ; Mineralocorticoid Receptor Antagonists/administration & dosage ; Practice Guidelines as Topic ; Sodium-Glucose Transporter 2 Inhibitors/administration & dosage ; Stroke Volume
Czasopismo naukowe
Tytuł :
The Development of Minitablets for a Pediatric Dosage Form for a Combination Therapy.
Autorzy :
Zhang D; Department of Pharmaceutical Sciences, Merck & Co., Inc, Kenilworth, NJ 07033, USA. Electronic address: .
Rumondor ACF; Department of Pharmaceutical Sciences, Merck & Co., Inc, Kenilworth, NJ 07033, USA.
Zhu W; Department of Pharmaceutical Sciences, Merck & Co., Inc, Kenilworth, NJ 07033, USA.
Colace T; Department of Pharmaceutical Sciences, Merck & Co., Inc, Kenilworth, NJ 07033, USA.
Marota M; Department of Pharmaceutical Sciences, Merck & Co., Inc, Kenilworth, NJ 07033, USA.
Mora J; Department of Pharmaceutical Sciences, Merck & Co., Inc, Kenilworth, NJ 07033, USA.
Liu Z; Department of Pharmaceutical Sciences, Merck & Co., Inc, Kenilworth, NJ 07033, USA.
Li Y; Department of Pharmaceutical Sciences, Merck & Co., Inc, Kenilworth, NJ 07033, USA. Electronic address: .
Pokaż więcej
Źródło :
Journal of pharmaceutical sciences [J Pharm Sci] 2020 Dec; Vol. 109 (12), pp. 3590-3597. Date of Electronic Publication: 2020 Sep 01.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Combinations*
Tablets*
Taste*
Animals ; Child ; Dogs ; Humans ; Solubility
Czasopismo naukowe
Tytuł :
New weapons to fight a new enemy: A systematic review of drug combinations against the drug-resistant fungus Candida auris.
Autorzy :
Aghaei Gharehbolagh S; Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Izadi A; Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Talebi M; Department of Medicinal Chemistry, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Sadeghi F; Department of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Zarrinnia A; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Zarei F; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Darmiani K; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Borman AM; Public Health England UK National Mycology Reference Laboratory, Southmead Hospital Bristol, Bristol, UK.; Medical Research Council Centre for Medical Mycology (MRC CMM), University of Exeter, Exeter, UK.
Mahmoudi S; Department of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło :
Mycoses [Mycoses] 2021 Nov; Vol. 64 (11), pp. 1308-1316. Date of Electronic Publication: 2021 Apr 03.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Antifungal Agents/*administration & dosage
Candida/*drug effects
Candidiasis/*drug therapy
Cross Infection/*microbiology
Anti-Bacterial Agents/administration & dosage ; Anti-Inflammatory Agents, Non-Steroidal/administration & dosage ; Anticholesteremic Agents/administration & dosage ; Antidepressive Agents/administration & dosage ; Antineoplastic Agents/administration & dosage ; Antioxidants/administration & dosage ; Antiparasitic Agents/administration & dosage ; Biological Products/administration & dosage ; Candidiasis/microbiology ; Cross Infection/drug therapy ; Drug Combinations ; Drug Resistance, Fungal ; Humans ; Vasodilator Agents/administration & dosage
Czasopismo naukowe
Tytuł :
A foundation for reference models for drug combinations with an application to Loewe's reference model.
Autorzy :
De Mulder W; Department of Biology, NTNU, Realfagbygget, Trondheim, Norway. .
Kuiper M; Department of Biology, NTNU, Realfagbygget, Trondheim, Norway.
Pokaż więcej
Źródło :
BMC bioinformatics [BMC Bioinformatics] 2020 Oct 15; Vol. 21 (1), pp. 460. Date of Electronic Publication: 2020 Oct 15.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Combinations*
Models, Theoretical*
Dose-Response Relationship, Drug ; Drug Interactions ; Drug Synergism ; Humans ; Pharmaceutical Preparations/metabolism ; Reference Standards
Czasopismo naukowe
Tytuł :
Safety and efficacy of intermittent presumptive treatment with sulfadoxine-pyrimethamine using rapid diagnostic test screening and treatment with dihydroartemisinin-piperaquine at the first antenatal care visit (IPTp-SP+): study protocol for a randomized controlled trial.
Autorzy :
Kabuya JB; Department of Clinical Sciences, Tropical Diseases Research Centre, P.O. Box 71769, Copperbelt Province, Ndola, Zambia. .
Ippolito MM; Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Sikalima J; Department of Clinical Sciences, Tropical Diseases Research Centre, P.O. Box 71769, Copperbelt Province, Ndola, Zambia.
Tende C; Department of Clinical Sciences, Tropical Diseases Research Centre, P.O. Box 71769, Copperbelt Province, Ndola, Zambia.
Champo D; Department of Clinical Sciences, Tropical Diseases Research Centre, P.O. Box 71769, Copperbelt Province, Ndola, Zambia.
Mwakazanga D; Department of Clinical Sciences, Tropical Diseases Research Centre, P.O. Box 71769, Copperbelt Province, Ndola, Zambia.
Young AMP; Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Mulenga M; Department of Clinical Sciences, Tropical Diseases Research Centre, P.O. Box 71769, Copperbelt Province, Ndola, Zambia.
Chongwe G; Department of Clinical Sciences, Tropical Diseases Research Centre, P.O. Box 71769, Copperbelt Province, Ndola, Zambia.
Manyando C; Department of Clinical Sciences, Tropical Diseases Research Centre, P.O. Box 71769, Copperbelt Province, Ndola, Zambia.
Pokaż więcej
Źródło :
Trials [Trials] 2021 Nov 20; Vol. 22 (1), pp. 820. Date of Electronic Publication: 2021 Nov 20.
Typ publikacji :
Clinical Trial Protocol; Journal Article
MeSH Terms :
Antimalarials*/adverse effects
Artemisinins*/adverse effects
HIV Infections*/drug therapy
Pregnancy Complications, Parasitic*/diagnosis
Pregnancy Complications, Parasitic*/drug therapy
Pregnancy Complications, Parasitic*/prevention & control
Clinical Trials, Phase III as Topic ; Diagnostic Tests, Routine ; Drug Combinations ; Female ; Humans ; Infant ; Placenta ; Pregnancy ; Prenatal Care ; Pyrimethamine/adverse effects ; Quinolines ; Randomized Controlled Trials as Topic ; Retrospective Studies ; Sulfadoxine
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies